Schwannoma is a benign tumor arising from Schwann cells, which form the protective sheaths surrounding peripheral and cranial nerves. Tumors are typically encapsulated and slow-growing. Recurrence after treatment is infrequent, and malignant transformation has been reported in only rare cases. Recognized subtypes include acoustic neuroma, trigeminal schwannoma, cellular schwannoma, plexiform schwannoma, melanotic neurilemmoma, and schwannomatosis, among others. The condition is estimated to affect approximately 1 to 9 individuals per 100,000.

Structured phenotype data are not available for schwannoma in this packet. Clinical presentation varies with the nerve affected and tumor location. Compression of the involved nerve or adjacent structures typically underlies symptom development, with individual presentation differing across subtypes and anatomical sites.

No causative germline genetic variants are identified in this packet, and no inheritance pattern is established for schwannoma in the available data. The condition arises from Schwann cells associated with peripheral or cranial nerves. The specific cellular events underlying tumor formation are not detailed in the available data.

Evaluation typically involves imaging studies to characterize tumor location, size, and relationship to adjacent neural structures. Pathological examination of tumor tissue confirms the Schwann cell origin and histologic subtype. Clinical approach varies by anatomical location and tumor characteristics.

Treatment planning for schwannoma depends on tumor size, location, rate of growth, and proximity to critical neural structures. Management may involve a multidisciplinary care team and may include surgical resection or radiation-based local therapies. No treatments are specifically approved for schwannoma at this time. An investigational agent is under development through orphan drug designation.

Schwannoma is generally a benign condition with infrequent recurrence following management. Malignant transformation is rare, as noted in the condition's definition. Outcomes vary by tumor location, size, and the approach taken.

Schwannoma is an active area of clinical research, with numerous ongoing clinical trials examining diagnostic and therapeutic approaches across tumor subtypes. Areas of investigation include pain management, targeted therapies for specific schwannoma subtypes, radiation techniques for intracranial tumors, rehabilitation strategies, and novel imaging methods. Individuals interested in clinical trial participation may search ClinicalTrials.gov for available studies.